PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.77%
Negative revenue growth while 3141.T stands at 3.98%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.75%
Negative gross profit growth while 3141.T is at 7.01%. Joel Greenblatt would examine cost competitiveness or demand decline.
-31.49%
Negative EBIT growth while 3141.T is at 26.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-35.54%
Negative operating income growth while 3141.T is at 27.39%. Joel Greenblatt would press for urgent turnaround measures.
-32.23%
Negative net income growth while 3141.T stands at 23.72%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.22%
Negative EPS growth while 3141.T is at 23.68%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-32.22%
Negative diluted EPS growth while 3141.T is at 23.86%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
58.88%
10Y revenue/share CAGR at 50-75% of 3141.T's 81.80%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-14.93%
Negative 5Y CAGR while 3141.T stands at 57.08%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
36.94%
3Y revenue/share CAGR at 75-90% of 3141.T's 47.13%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.10%
Below 50% of 3141.T's 606.53%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-26.01%
Negative 5Y net income/share CAGR while 3141.T is 72.92%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
18.92%
Below 50% of 3141.T's 98.20%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
175.31%
10Y equity/share CAGR in line with 3141.T's 182.73%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
21.78%
Below 50% of 3141.T's 112.32%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.66%
3Y equity/share CAGR 1.25-1.5x 3141.T's 46.84%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
12.50%
Below 50% of 3141.T's 220.00%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-18.18%
Negative near-term dividend growth while 3141.T invests at 96.92%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
8.70%
Our AR growth while 3141.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
9.23%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.72%
Asset growth well under 50% of 3141.T's 5.55%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.25%
75-90% of 3141.T's 3.97%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-7.42%
We’re deleveraging while 3141.T stands at 42.24%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.66%
SG&A declining or stable vs. 3141.T's 3.98%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.